@lowey133 : AML affects 20,000 people each year in the US and over 2,500 in the UK, lets hope the trials are successful. And if they are then the company should be worth a lot more.
Blubay: agreed, this has turned from get rich quick AIM to a company that will return profit on production. The Get Rich Quick was for those that bough in January at 0.2 and sold in February at 2.4. Until concrete numbers of reservoir size and likely profits this share is probably going to hover around 0.9 to 1.1. I'm not even sure the ML will move the needle significantly.
I'm firmly of the belief that cultivated meat will have to be a thing in order for governments to reach Net Zero targets. Then add all the other benefits. Wait till Elon needs it for his trips to Mars. BOOM.
I can't help feeling the Β£350k for Prevail is a rounding error on a Spreadsheet and its money they can easily afford to loose but if CAR-T, CBR, CDX works then it was well worth the risk.